US promises tariff relief in talks with Audi on Georgia plant, sources say

More in Business

• Gilead hikes 2026 sales outlook, says Medicare cuts Biktarvy price by 38% starting in 2028

  The pharmaceutical giant adjusted its medium-term financial projections upward to reflect stronger expectations for its broader portfolio. Meanwhile, federal health officials have targeted the flagship HIV medication for substantial government price reductions later this decade. These impending regulatory discounts will reshape the drugmaker's long-term revenue profile under federal healthcare programs.

  1 min read
• Wall Street's AI fears slash Google value by $500bn

  Alphabet's aggressive push into artificial intelligence has begun cannibalizing its primary moneymaker by curbing the volume of advertisements sold through standard search queries. Massive capital expenditures dedicated to funding these advanced technologies triggered a rare quarterly cash deficit, intensifying investor panic over whether big tech firms can monetize AI before eroding their established profit centers.

  1 min read
• CCPA penalises Justdial, Sunrise Foods for safety, misleading product claims

  Regulatory scrutiny is intensifying across Indian commerce platforms to safeguard consumer welfare and enforce transparent product descriptions. Authorities acted against unsafe explosive sales listings and deceptive whole-wheat marketing to establish stricter platform accountability. These enforcement measures signal that intermediaries and food brands must independently verify compliance rather than relying on technical disclaimers.

  1 min read